骨髓纤维化中的干细胞移植：是时候实现个性化了。 - Suppr

Suppr

超能文献

Stem cell transplant in MF: it's time to personalize.

作者信息

Passamonti Francesco

机构信息

University of Insubria.

出版信息

Blood. 2019 May 16;133(20):2118-2120. doi: 10.1182/blood-2019-03-900860.

DOI:10.1182/blood-2019-03-900860

PMID:31097535

Abstract

摘要

相似文献

Stem cell transplant in MF: it's time to personalize.

Blood. 2019 May 16;133(20):2118-2120. doi: 10.1182/blood-2019-03-900860.

Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.

Ann Hematol. 2016 Oct;95(10):1627-36. doi: 10.1007/s00277-016-2758-z. Epub 2016 Aug 2.

Syngeneic stem cell transplant for spent-phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesis.

Br J Haematol. 2002 Apr;117(1):245-6. doi: 10.1046/j.1365-2141.2002.03387.x.

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.

Br J Haematol. 2018 Aug;182(3):418-422. doi: 10.1111/bjh.15407. Epub 2018 May 29.

Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S34-42. doi: 10.1016/j.clml.2015.02.034.

Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis.

Int J Hematol. 2002 Aug;76 Suppl 2:29-34. doi: 10.1007/BF03165082.

The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.

Hematol Oncol Stem Cell Ther. 2016 Sep;9(3):96-104. doi: 10.1016/j.hemonc.2016.07.002. Epub 2016 Aug 6.

[Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms].

Rinsho Ketsueki. 2019;60(9):1148-1156. doi: 10.11406/rinketsu.60.1148.

Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis.

Exp Clin Transplant. 2019 Feb;17(1):93-96. doi: 10.6002/ect.2016.0007. Epub 2016 Nov 18.

Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis.

Biol Blood Marrow Transplant. 2014 Jun;20(6):812-5. doi: 10.1016/j.bbmt.2014.02.019. Epub 2014 Mar 1.

引用本文的文献

Prognostic and Predictive Models in Myelofibrosis.

Curr Hematol Malig Rep. 2024 Oct;19(5):223-235. doi: 10.1007/s11899-024-00739-6. Epub 2024 Aug 24.

Myelofibrosis and allogeneic transplantation: critical points and challenges.

Front Oncol. 2024 Jun 20;14:1396435. doi: 10.3389/fonc.2024.1396435. eCollection 2024.

Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.

Clin Exp Med. 2023 Dec;23(8):4199-4217. doi: 10.1007/s10238-023-01189-9. Epub 2023 Sep 25.

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation.

Hemasphere. 2023 Jun 30;7(7):e921. doi: 10.1097/HS9.0000000000000921. eCollection 2023 Jul.

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.

Ann Hematol. 2023 Sep;102(9):2517-2527. doi: 10.1007/s00277-023-05312-4. Epub 2023 Jun 17.

Prognostication in myeloproliferative neoplasms, including mutational abnormalities.

Blood Res. 2023 Apr 30;58(S1):S37-S45. doi: 10.5045/br.2023.2023038. Epub 2023 Mar 16.

Myelofibrosis.

Blood. 2023 Apr 20;141(16):1954-1970. doi: 10.1182/blood.2022017423.

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation.

Diagnostics (Basel). 2022 Oct 14;12(10):2493. doi: 10.3390/diagnostics12102493.

High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis.

Hemasphere. 2022 Sep 30;6(10):e784. doi: 10.1097/HS9.0000000000000784. eCollection 2022 Oct.

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.

Curr Hematol Malig Rep. 2022 Oct;17(5):127-139. doi: 10.1007/s11899-022-00672-6. Epub 2022 Sep 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验